RETRACTED: Theaflavin ameliorates behavioral deficits, biochemical indices and monoamine transporters expression against subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson’s disease
Authors:
- U. JanakiramanUJU. Janakiraman
- T. ManivasagamTMT. Manivasagam
- 1 August 2012
- journal article
- retracted article
- Published by Elsevier in Neuroscience
- Vol. 218, 257-267
Abstract
No abstract availableKeywords
Funding Information
- University Grants Commission
This publication has 65 references indexed in Scilit:
- Green Tea Catechin, Epigallocatechin Gallate, Suppresses Signaling by the dsRNA Innate Immune Receptor RIG-IPLOS ONE, 2010
- Resveratrol as a Therapeutic Agent for Neurodegenerative DiseasesMolecular Neurobiology, 2010
- Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's DiseaseThe Journal of Neuroscience, 2010
- Neuroprotective molecular mechanisms of (−)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic propertiesGenes & Nutrition, 2009
- Flavonoids and brain health: multiple effects underpinned by common mechanismsGenes & Nutrition, 2009
- Ashwagandha leaf extract: A potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's diseaseNeuroscience Letters, 2009
- Oxidative Stress in Parkinson's DiseaseAnnals of the New York Academy of Sciences, 2008
- Differential Effects of Black versus Green Tea on Risk of Parkinson's Disease in the Singapore Chinese Health StudyAmerican Journal of Epidemiology, 2007
- Theaflavin Ameliorates Cerebral Ischemia‐Reperfusion Injury in Rats Through Its Anti‐Inflammatory Effect and Modulation of STAT‐1Mediators of Inflammation, 2006
- Glutathione depletion in rat brain does not cause nigrostriatal pathway degenerationJournal of Neural Transmission, 1997